Answers are grounded in this paper and cite their sources.
Technology for the expression of recombinant proteins continues to evolve. Mammalian cells such as those of baby-hamster kidney and Chinese hamster ovary, together with yeast expression systems, have been used successfully for some two decades. Improved translational and secretory pathways have been identified, as well as improved bioreactor design, including improvements in oxygenation. However, these systems do have individual problems and limitations. Plant biotechnology has evolved at a pace exceeding that of animal biotechnology, with the implementation of transgenic plants with increased resistance to disease as well as improved ‘characteristics’. It is noted that the development of transgenic plants with increased disease resistance, such as BT corn [1], has overshadowed other developments in plant biotechnology. In particular, the use of plant systems for the expression of recombinant proteins has been somewhat neglected. A series of review articles in this issue of Biotechnology and Applied Biochemistry from the laboratory of Dr. Reiner Fischer, review the current status of the use of plant systems for the expression of recombinant proteins. Plant systems provide several potential advantages to animal-cell-based systems. First, animal pathogens would appear to be absent. Secondly, the yield per wet tissue weight can be substantially larger than that seen with animal-cell-based systems. Finally, it would appear that plant systems can perform most of the post-translatational and co-translational modifications observed with animal-cell systems. It is noted that a group from the U.S. Department of Energy Pacific Northwest National Laboratory in Richland, WA, U.S.A., have reported the expression of the blood coagulation factor Factor VIII and the enzyme thrombin in tobacco (Nicotiana tabacum) plants [2]. In preparation for consideration of the reviews mentioned below, the reader is directed toward several recent global-review articles on the use of plants as vehicles for the production of recombinant proteins [3–8]. The first of these reviews, ‘Towards molecular farming in the future: moving from diagnostic protein and antibody production in microbes to plants’, concerns the use of transgenic plants for the production of recombinant proteins. A useful example is the production of recombinant antibodies in tobacco (N. tabacum). The yield of tissue per acre of tobacco is extremely high, thus providing a high-level expression system. A second review, ‘Towards molecular farming in the future: using plant-cell suspension cultures as bioreactors’ discusses the use of plant-cell suspensions for the production of recombinant proteins. Large-scale cell culture of plant-cell suspensions can be obtained through the use of technology similar to that developed for animal-cell culture. An example is presented using Agrobacterium transformation of N. tabacum. Cell culture can be obtained either through the use of transgenic plants or by co-cultivation of suspended cells and agrobacteria. A third review, ‘Towards molecular farming in the future: transient protein expression in plants’, discusses transient expression of recombinant proteins in plants using viral vectors. This approach is fast, but lacks the potential for production volume seen with transgenic plants. This approach is useful for the rapid expression of large amounts of protein for characterization. A companion review in this issue, ‘Towards molecular farming in the future: Pichia pastoris-based production of single-chain antibody fragments’, reviews the technology of single-chain antibody production in this yeast system. In this regard, the reader is directed towards two recent papers in Biotechnology and Applied Biochemistry [9,10]. These reviews should provide an overview of current issues in the use of plant tissues for the expression of recombinant proteins.
No takes yet. Share an insight, caveat, or question.
Lundblad et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: